D-103 | Safety and Efficacy of Paclitaxel-Coated Balloon Angioplasty for Coronary In-stent Restenosis in Patients with Chronic Kidney Disease: A Sub-Analysis of the AGENT IDE Trial

Chronic kidney disease (CKD) is a risk factor for coronary in-stent restenosis (ISR). Drug-coated balloons (DCB) are known to reduce target lesion failure (TLF) compared with conventional balloon angioplasty (BA) in ISR. Little is known, however, regarding the impact of CKD on TLF in patients undergoing DCB treatment for ISR.

Authors

Institutions

Publication Details

Journal
Journal of the Society for Cardiovascular Angiography & Interventions
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jscai.2025.103235
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

D-103 | Safety and Efficacy of Paclitaxel-Coated Balloon Angioplasty for Coronary In-stent Restenosis in Patients with Chronic Kidney Disease: A Sub-Analysis of the AGENT IDE Trial

Wayne Batchelor, Behnam Tehrani, Steven Gregg Rudick, J. Aaron Grantham et al.
Journal of the Society for Cardiovascular Angiography & Interventions
Coronary Interventions and Diagnostics
article

D-103 | Safety and Efficacy of Paclitaxel-Coated Balloon Angioplasty for Coronary In-stent Restenosis in Patients with Chronic Kidney Disease: A Sub-Analysis of the AGENT IDE Trial

Wayne Batchelor, Behnam Tehrani, Steven Gregg Rudick, J. Aaron Grantham, William Bachinsky, John D. Altman, Cinthia Bateman, Ajay Jayant Kirtane, Jeffrey W. Moses, Jennifer A. Tremmel, J. Dawn Abbott, Ilan Vavilin, Robert W. Yeh, Rafael Cavalcante, Suhail Dohad, William Nicholson, Brian Jefferson, Robert Stoler, Richard Shlofmitz
article en

Abstract

Chronic kidney disease (CKD) is a risk factor for coronary in-stent restenosis (ISR). Drug-coated balloons (DCB) are known to reduce target lesion failure (TLF) compared with conventional balloon angioplasty (BA) in ISR. Little is known, however, regarding the impact of CKD on TLF in patients undergoing DCB treatment for ISR.

Journal of the Society for Cardiovascular Angiography & InterventionsVol. 4(5)
Cedars-Sinai Medical Center (US), Beth Israel Deaconess Medical Center (US), NewYork–Presbyterian Hospital (US), Providence College (US), Rhode Island Hospital (US), Inova Fairfax Hospital (US), Emory University Hospital (US), UPMC Central Pa (US), New York Hospital Queens (US), Boston Scientific (United States) (US), Centennial Medical Center (US), St. Francis Hospital (US), St. Luke's Hospital (US), Christ Hospital (US), St. Anthony Hospital (US), Stanford Medicine (US), Cardiovascular Research Foundation (US), Lifespan (US), Alaska Heart and Vascular Institute (US), Baylor Jack and Jane Hamilton Heart and Vascular Hospital (US), Christ Hospital (US), St. Vincent's Medical Center (US), Columbia University (US), Stanford University (US)
Boston Scientific Corporation
Good health and well-being
Openalex Percentile: Top 84%
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.